Keywords: Pfizer, oehringer Ingelheim, FDA, Spiriva, COPD, Chantix, Pay-to-delay, European Commission, Law suits
US FDA backs safety of Pfizer/Boehringer’s Spiriva HandiHaler; Pfizer admits EU investigation; gets sued over Chantix
Article | 15 January 2010
The US Food and Drug Administration has said that recent data do not show a connection between a popular inhaler ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
